Last reviewed · How we verify
NCT07213388: IVRTE
Immersive Virtual Reality vs Treadmill Exercise Project
NA trial testing VRPA in Control in 61 participants. Completed in 22 October 2025.
22 October 2025
Quick facts
| Lead sponsor | Rowan University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | factorial |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 61 |
| Start date | 1 September 2024 |
| Primary completion | 22 October 2025 |
| Estimated completion | 22 October 2025 |
| Sites | 1 location across United States |
Drugs / interventions tested
- VRPA
- Treadmill
- Control
Conditions studied
- Control — all drugs for Control →
- Virtual Reality Physical Activity — all drugs for Virtual Reality Physical Activity →
- Treadmill — all drugs for Treadmill →
Sponsor
Rowan University
Who can join
Adults 18 to 64, any sex, with Control or Virtual Reality Physical Activity. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this research project is to examine the feasibility and acceptability of a virtual reality-based physical activity (VRPA) intervention for inactive adults compared to more traditional forms of physical activity. The project will explore the relationship between VRPA engagement and cognition, biological measures (calories burned, heart rate, and active minutes), rate of perceived exertion, flow, affect, and enjoyment in physical activity as well.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07213388
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Control
Currently open trials in the same condition.
- NCT06750107 — Testing the Efficacy of Safe South Africa · Phase 3 · active not recruiting
- NCT06116292 — Impact of the Implementation of a Telemedicine Program on Patients Diagnosed with Asthma · NA · recruiting
- NCT06169540 — Salivary Extracellular Vesicle Associated lncRNAs in Heart Failure (SEAL-HF) · recruiting
- NCT05517811 — Pre- and Post-operative TEG Indices in Patients With or Without Adenocarcinoma Undergoing Surgical Resection · recruiting
Other Rowan University trials
Trials by the same sponsor.
- NCT06235463 — Pedal Pump and Leg Lymphedema · NA · recruiting
- NCT06350604 — Project WHADE: A Partner-Based Physical Activity Program for Women · NA · completed
- NCT07256808 — Medial Tibial Stress Syndrome Prevention · NA · completed
- NCT06651671 — Tissue Changes Following Thoracic Myofascial Release · NA · completed
- NCT05224154 — Re-Connect Application for Smoking Cessation · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07213388 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Rowan University
- Last refreshed: 16 January 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07213388.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing